The Board of Trustees of the Leland Stanford Junior University
发明人:
Helms, Jill,Dhamdhere, Girija
申请号：
AU2019222935
公开号：
AU2019222935A1
申请日:
2019.08.30
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2019222935A120190919.pdf#####ABSTRACT The present invention concerns the enhancement of cell survival and osteogenic potential of bone graft by ex vivo treatment with a Wnt polypeptide, such as a liposomal Wnt polypeptide. In particular, the invention concerns the ex vivo treatment of bone grafts with a human Wnt3a protein, preferably liposomal human Wnt3a (L-Wnt3a).
